Dade analyser "reliable and cost-effective":
This article was originally published in Clinica
Executive Summary
A US clinical study has backed Dade Behring's automated system for measuring platelet function as a reliable and cost-effective tool for detecting certain bleeding disorders, such as von Willebrand disease and aspirin-induced bleeding. The PFA-100 platelet function analyser system, commercially available in the US and Europe since 1997, was effective at detecting platelet dysfunction in patients with von Willebrand disease and produced few false-positive readings. "By reducing false-positives, clinicians can avoid re-testing, often with a time consuming and more expensive procedure," said the Deerfield, Illinois-based company.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.